0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Immunosuppressant Drugs Market Insights, Forecast to 2027
Published Date: October 2021
|
Report Code: QYRE-Auto-13N6980
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global and United States Immunosuppressant Drugs Market Insights Forecast to 2027

Global and United States Immunosuppressant Drugs Market Insights, Forecast to 2027

Code: QYRE-Auto-13N6980
Report
October 2021
140 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Immunosuppressant Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Immunosuppressant Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

Calcineurin Inhibitors
MTOR Inhibitors
Anti-proliferative Agents
Steroids
Antibodies

Segment by Application

Kidney
Bone Marrow
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Novartis
Astellas Pharma
Roche
Pfizer
Sanofi
Allergan
Bristol-Myers Squibb
AbbVie
Veloxis Pharmaceuticals
GSK
1 Study Coverage
1.1 Immunosuppressant Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Immunosuppressant Drugs Market Size Growth Rate by Type
1.2.2 Calcineurin Inhibitors
1.2.3 MTOR Inhibitors
1.2.4 Anti-proliferative Agents
1.2.5 Steroids
1.2.6 Antibodies
1.3 Market by Application
1.3.1 Global Immunosuppressant Drugs Market Size Growth Rate by Application
1.3.2 Kidney
1.3.3 Bone Marrow
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Immunosuppressant Drugs Market Size, Estimates and Forecasts
2.1.1 Global Immunosuppressant Drugs Revenue 2016-2027
2.1.2 Global Immunosuppressant Drugs Sales 2016-2027
2.2 Global Immunosuppressant Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Immunosuppressant Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Immunosuppressant Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Immunosuppressant Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Immunosuppressant Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Immunosuppressant Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Immunosuppressant Drugs Revenue Forecast by Region (2022-2027)
3 Global Immunosuppressant Drugs Competitor Landscape by Players
3.1 Global Top Immunosuppressant Drugs Manufacturers by Sales
3.1.1 Global Immunosuppressant Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Immunosuppressant Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Immunosuppressant Drugs Manufacturers by Revenue
3.2.1 Key Immunosuppressant Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Immunosuppressant Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Immunosuppressant Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Immunosuppressant Drugs Revenue in 2020
3.2.6 Global Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Immunosuppressant Drugs Price by Manufacturers
3.4 Global Immunosuppressant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunosuppressant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Immunosuppressant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Immunosuppressant Drugs Market Size by Type (2016-2021)
4.1.1 Global Immunosuppressant Drugs Sales by Type (2016-2021)
4.1.2 Global Immunosuppressant Drugs Revenue by Type (2016-2021)
4.1.3 Immunosuppressant Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Immunosuppressant Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Immunosuppressant Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Immunosuppressant Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Immunosuppressant Drugs Market Size by Application (2016-2021)
5.1.1 Global Immunosuppressant Drugs Sales by Application (2016-2021)
5.1.2 Global Immunosuppressant Drugs Revenue by Application (2016-2021)
5.1.3 Immunosuppressant Drugs Price by Application (2016-2021)
5.2 Immunosuppressant Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Immunosuppressant Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Immunosuppressant Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Immunosuppressant Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Immunosuppressant Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Immunosuppressant Drugs Sales YoY Growth 2016-2027
6.1.2 United States Immunosuppressant Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Immunosuppressant Drugs Market Share in Global Market 2016-2027
6.2 United States Immunosuppressant Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Immunosuppressant Drugs Players by Sales (2016-2021)
6.2.2 United States Top Immunosuppressant Drugs Players by Revenue (2016-2021)
6.3 United States Immunosuppressant Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Immunosuppressant Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Immunosuppressant Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Immunosuppressant Drugs Price by Type (2016-2021)
6.4 United States Immunosuppressant Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Immunosuppressant Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Immunosuppressant Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Immunosuppressant Drugs Price Forecast by Type (2022-2027)
6.5 United States Immunosuppressant Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Immunosuppressant Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Immunosuppressant Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Immunosuppressant Drugs Price by Application (2016-2021)
6.6 United States Immunosuppressant Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Immunosuppressant Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Immunosuppressant Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Immunosuppressant Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Immunosuppressant Drugs Market Size YoY Growth 2016-2027
7.2 North America Immunosuppressant Drugs Market Facts & Figures by Country
7.2.1 North America Immunosuppressant Drugs Sales by Country (2016-2021)
7.2.2 North America Immunosuppressant Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Immunosuppressant Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Immunosuppressant Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Immunosuppressant Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Immunosuppressant Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Immunosuppressant Drugs Market Size YoY Growth 2016-2027
9.2 Europe Immunosuppressant Drugs Market Facts & Figures by Country
9.2.1 Europe Immunosuppressant Drugs Sales by Country (2016-2021)
9.2.2 Europe Immunosuppressant Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Immunosuppressant Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Immunosuppressant Drugs Market Facts & Figures by Country
10.2.1 Latin America Immunosuppressant Drugs Sales by Country (2016-2021)
10.2.2 Latin America Immunosuppressant Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Immunosuppressant Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Immunosuppressant Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Immunosuppressant Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Immunosuppressant Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Immunosuppressant Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Astellas Pharma
12.2.1 Astellas Pharma Corporation Information
12.2.2 Astellas Pharma Description and Business Overview
12.2.3 Astellas Pharma Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Astellas Pharma Immunosuppressant Drugs Products Offered
12.2.5 Astellas Pharma Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Immunosuppressant Drugs Products Offered
12.3.5 Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Immunosuppressant Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Immunosuppressant Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 Allergan
12.6.1 Allergan Corporation Information
12.6.2 Allergan Description and Business Overview
12.6.3 Allergan Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allergan Immunosuppressant Drugs Products Offered
12.6.5 Allergan Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Corporation Information
12.7.2 Bristol-Myers Squibb Description and Business Overview
12.7.3 Bristol-Myers Squibb Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bristol-Myers Squibb Immunosuppressant Drugs Products Offered
12.7.5 Bristol-Myers Squibb Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Description and Business Overview
12.8.3 AbbVie Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AbbVie Immunosuppressant Drugs Products Offered
12.8.5 AbbVie Recent Development
12.9 Veloxis Pharmaceuticals
12.9.1 Veloxis Pharmaceuticals Corporation Information
12.9.2 Veloxis Pharmaceuticals Description and Business Overview
12.9.3 Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Veloxis Pharmaceuticals Immunosuppressant Drugs Products Offered
12.9.5 Veloxis Pharmaceuticals Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Description and Business Overview
12.10.3 GSK Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK Immunosuppressant Drugs Products Offered
12.10.5 GSK Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Immunosuppressant Drugs Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Immunosuppressant Drugs Industry Trends
13.2 Immunosuppressant Drugs Market Drivers
13.3 Immunosuppressant Drugs Market Challenges
13.4 Immunosuppressant Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunosuppressant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Immunosuppressant Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Calcineurin Inhibitors
    Table 3. Major Manufacturers of MTOR Inhibitors
    Table 4. Major Manufacturers of Anti-proliferative Agents
    Table 5. Major Manufacturers of Steroids
    Table 6. Major Manufacturers of Antibodies
    Table 7. Global Immunosuppressant Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
    Table 8. Global Immunosuppressant Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
    Table 9. Global Immunosuppressant Drugs Sales by Regions (2016-2021) & (K MT)
    Table 10. Global Immunosuppressant Drugs Sales Market Share by Regions (2016-2021)
    Table 11. Global Immunosuppressant Drugs Revenue by Regions (2016-2021) & (US$ Million)
    Table 12. Global Immunosuppressant Drugs Sales Forecast by Region (2022-2027) & (K MT)
    Table 13. Global Immunosuppressant Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 14. Global Immunosuppressant Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 15. Global Immunosuppressant Drugs Revenue Market Share Forecast by Region (2022-2027)
    Table 16. Global Immunosuppressant Drugs Sales by Manufacturers (2016-2021) (K MT)
    Table 17. Global Immunosuppressant Drugs Sales Share by Manufacturers (2016-2021)
    Table 18. Ranking of Global Top Immunosuppressant Drugs Manufacturers by Revenue (US$ Million) in 2020
    Table 19. Immunosuppressant Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 20. Immunosuppressant Drugs Revenue Share by Manufacturers (2016-2021)
    Table 21. Global Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 22. Global Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunosuppressant Drugs as of 2020)
    Table 23. Key Manufacturers Immunosuppressant Drugs Price (2016-2021) (USD/MT)
    Table 24. Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Immunosuppressant Drugs Product Type
    Table 26. Date of International Manufacturers Enter into Immunosuppressant Drugs Market
    Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 28. Global Immunosuppressant Drugs Sales by Type (2016-2021) (K MT)
    Table 29. Global Immunosuppressant Drugs Sales Share by Type (2016-2021)
    Table 30. Global Immunosuppressant Drugs Revenue by Type (2016-2021) (US$ Million)
    Table 31. Global Immunosuppressant Drugs Revenue Share by Type (2016-2021)
    Table 32. Immunosuppressant Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
    Table 33. Global Immunosuppressant Drugs Sales Forecast by Type (2022-2027) & (K MT)
    Table 34. Global Immunosuppressant Drugs Sales Market Share Forecast by Type (2022-2027)
    Table 35. Global Immunosuppressant Drugs Revenue Forecast V (2022-2027) & (US$ Million)
    Table 36. Global Immunosuppressant Drugs Revenue Market Share Forecast by Type (2022-2027)
    Table 37. Global Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
    Table 38. Global Immunosuppressant Drugs Sales by Application (2016-2021) (K MT)
    Table 39. Global Immunosuppressant Drugs Sales Share by Application (2016-2021)
    Table 40. Global Immunosuppressant Drugs Revenue by Application (2016-2021) (US$ Million)
    Table 41. Global Immunosuppressant Drugs Revenue Share by Application (2016-2021)
    Table 42. Immunosuppressant Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
    Table 43. Global Immunosuppressant Drugs Sales Forecast by Application (2022-2027) & (K MT)
    Table 44. Global Immunosuppressant Drugs Sales Market Share Forecast by Application (2022-2027)
    Table 45. Global Immunosuppressant Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 46. Global Immunosuppressant Drugs Revenue Market Share Forecast by Application (2022-2027)
    Table 47. Global Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
    Table 48. United States Immunosuppressant Drugs Sales (K MT) of Key Companies (2016-2021)
    Table 49. United States Immunosuppressant Drugs Sales Share by Company (2016-2021)
    Table 50. United States Immunosuppressant Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 51. United States Immunosuppressant Drugs Revenue Share by Company (2016-2021)
    Table 52. United States Immunosuppressant Drugs Sales (K MT) by Type (2016-2021)
    Table 53. United States Immunosuppressant Drugs Sales Share by Type (2016-2021)
    Table 54. United States Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 55. United States Immunosuppressant Drugs Price (USD/MT) by Type (2016-2021)
    Table 56. United States Immunosuppressant Drugs Sales (K MT) by Type (2022-2027)
    Table 57. United States Immunosuppressant Drugs Sales Share by Type (2022-2027)
    Table 58. United States Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 59. United States Immunosuppressant Drugs Revenue Share by Type (2022-2027)
    Table 60. United States Immunosuppressant Drugs Price (USD/MT) by Type (2022-2027)
    Table 61. United States Immunosuppressant Drugs Sales (K MT) by Application (2016-2021)
    Table 62. United States Immunosuppressant Drugs Sales Share by Application (2016-2021)
    Table 63. United States Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 64. United States Immunosuppressant Drugs Price (USD/MT) by Application (2016-2021)
    Table 65. United States Immunosuppressant Drugs Sales (K MT) by Application (2022-2027)
    Table 66. United States Immunosuppressant Drugs Sales Share by Application (2022-2027)
    Table 67. United States Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 68. United States Immunosuppressant Drugs Revenue Share by Application (2022-2027)
    Table 69. United States Immunosuppressant Drugs Price (USD/MT) by Application (2022-2027)
    Table 70. North America Immunosuppressant Drugs Sales by Country (2016-2021) & (K MT)
    Table 71. North America Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
    Table 72. North America Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 73. North America Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
    Table 74. Asia Pacific Immunosuppressant Drugs Sales by Region (2016-2021) & (K MT)
    Table 75. Asia Pacific Immunosuppressant Drugs Sales Market Share by Region (2016-2021)
    Table 76. Asia Pacific Immunosuppressant Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Immunosuppressant Drugs Revenue Market Share by Region (2016-2021)
    Table 78. Europe Immunosuppressant Drugs Sales by Country (2016-2021) & (K MT)
    Table 79. Europe Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
    Table 80. Europe Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 81. Europe Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
    Table 82. Latin America Immunosuppressant Drugs Sales by Country (2016-2021) & (K MT)
    Table 83. Latin America Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
    Table 84. Latin Americaa Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 85. Latin America Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Immunosuppressant Drugs Sales by Country (2016-2021) & (K MT)
    Table 87. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Country (2016-2021)
    Table 88. Middle East and Africa Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 89. Middle East and Africa Immunosuppressant Drugs Revenue Market Share by Country (2016-2021)
    Table 90. Novartis Corporation Information
    Table 91. Novartis Description and Business Overview
    Table 92. Novartis Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 93. Novartis Immunosuppressant Drugs Product
    Table 94. Novartis Recent Development
    Table 95. Astellas Pharma Corporation Information
    Table 96. Astellas Pharma Description and Business Overview
    Table 97. Astellas Pharma Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 98. Astellas Pharma Product
    Table 99. Astellas Pharma Recent Development
    Table 100. Roche Corporation Information
    Table 101. Roche Description and Business Overview
    Table 102. Roche Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 103. Roche Product
    Table 104. Roche Recent Development
    Table 105. Pfizer Corporation Information
    Table 106. Pfizer Description and Business Overview
    Table 107. Pfizer Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 108. Pfizer Product
    Table 109. Pfizer Recent Development
    Table 110. Sanofi Corporation Information
    Table 111. Sanofi Description and Business Overview
    Table 112. Sanofi Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 113. Sanofi Product
    Table 114. Sanofi Recent Development
    Table 115. Allergan Corporation Information
    Table 116. Allergan Description and Business Overview
    Table 117. Allergan Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 118. Allergan Product
    Table 119. Allergan Recent Development
    Table 120. Bristol-Myers Squibb Corporation Information
    Table 121. Bristol-Myers Squibb Description and Business Overview
    Table 122. Bristol-Myers Squibb Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 123. Bristol-Myers Squibb Product
    Table 124. Bristol-Myers Squibb Recent Development
    Table 125. AbbVie Corporation Information
    Table 126. AbbVie Description and Business Overview
    Table 127. AbbVie Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 128. AbbVie Product
    Table 129. AbbVie Recent Development
    Table 130. Veloxis Pharmaceuticals Corporation Information
    Table 131. Veloxis Pharmaceuticals Description and Business Overview
    Table 132. Veloxis Pharmaceuticals Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 133. Veloxis Pharmaceuticals Product
    Table 134. Veloxis Pharmaceuticals Recent Development
    Table 135. GSK Corporation Information
    Table 136. GSK Description and Business Overview
    Table 137. GSK Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 138. GSK Product
    Table 139. GSK Recent Development
    Table 140. Immunosuppressant Drugs Market Trends
    Table 141. Immunosuppressant Drugs Market Drivers
    Table 142. Immunosuppressant Drugs Market Challenges
    Table 143. Immunosuppressant Drugs Market Restraints
    Table 144. Immunosuppressant Drugs Customers List
    Table 145. Immunosuppressant Drugs Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immunosuppressant Drugs Product Picture
    Figure 2. Global Immunosuppressant Drugs Sales Market Share by Type in 2020 & 2027
    Figure 3. Calcineurin Inhibitors Product Picture
    Figure 4. MTOR Inhibitors Product Picture
    Figure 5. Anti-proliferative Agents Product Picture
    Figure 6. Steroids Product Picture
    Figure 7. Antibodies Product Picture
    Figure 8. Global Immunosuppressant Drugs Sales Market Share by Application in 2020 & 2027
    Figure 9. Kidney
    Figure 10. Bone Marrow
    Figure 11. Others
    Figure 12. Immunosuppressant Drugs Report Years Considered
    Figure 13. Global Immunosuppressant Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Immunosuppressant Drugs Market Size 2016-2027 (US$ Million)
    Figure 15. Global Immunosuppressant Drugs Sales 2016-2027 (K MT)
    Figure 16. Global Immunosuppressant Drugs Market Size Market Share by Region: 2021 Versus 2027
    Figure 17. Global Immunosuppressant Drugs Sales Market Share by Region (2016-2021)
    Figure 18. Global Immunosuppressant Drugs Sales Market Share by Region in 2020
    Figure 19. Global Immunosuppressant Drugs Revenue Market Share by Region (2016-2021)
    Figure 20. Global Immunosuppressant Drugs Revenue Market Share by Region in 2020
    Figure 21. Global Immunosuppressant Drugs Sales Share by Manufacturer in 2020
    Figure 22. The Top 10 and 5 Players Market Share by Immunosuppressant Drugs Revenue in 2020
    Figure 23. Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 24. Global Immunosuppressant Drugs Sales Market Share by Type (2016-2021)
    Figure 25. Global Immunosuppressant Drugs Sales Market Share by Type in 2020
    Figure 26. Global Immunosuppressant Drugs Revenue Market Share by Type (2016-2021)
    Figure 27. Global Immunosuppressant Drugs Revenue Market Share by Type in 2020
    Figure 28. Global Immunosuppressant Drugs Sales Market Share by Application (2016-2021)
    Figure 29. Global Immunosuppressant Drugs Sales Market Share by Application in 2020
    Figure 30. Global Immunosuppressant Drugs Revenue Market Share by Application (2016-2021)
    Figure 31. Global Immunosuppressant Drugs Revenue Market Share by Application in 2020
    Figure 32. United States Immunosuppressant Drugs Sales Growth Rate 2016-2027 (K MT)
    Figure 33. United States Immunosuppressant Drugs Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 34. United States Immunosuppressant Drugs Market Share in Global Market 2016-2027
    Figure 35. United States 5 and 10 Largest Immunosuppressant Drugs Players Market Share by Revenue in Immunosuppressant Drugs in 2020
    Figure 36. United States Immunosuppressant Drugs Revenue Share by Type (2016-2021)
    Figure 37. United States Immunosuppressant Drugs Revenue Growth Rate by Type in 2016 & 2020
    Figure 38. United States Immunosuppressant Drugs Revenue Share by Application (2016-2021)
    Figure 39. United States Immunosuppressant Drugs Revenue Growth Rate by Application in 2016 & 2020
    Figure 40. North America Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K MT)
    Figure 41. North America Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 42. North America Immunosuppressant Drugs Sales Market Share by Country in 2020
    Figure 43. North America Immunosuppressant Drugs Revenue Market Share by Country in 2020
    Figure 44. U.S. Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 45. U.S. Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Canada Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 47. Canada Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 48. Europe Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K MT)
    Figure 49. Europe Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 50. Europe Immunosuppressant Drugs Sales Market Share by Country in 2020
    Figure 51. Europe Immunosuppressant Drugs Revenue Market Share by Country in 2020
    Figure 52. Germany Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 53. Germany Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. France Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 55. France Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. U.K. Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 57. U.K. Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Italy Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 59. Italy Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Russia Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 61. Russia Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 62. Asia Pacific Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K MT)
    Figure 63. Asia Pacific Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 64. Asia Pacific Immunosuppressant Drugs Sales Market Share by Region in 2020
    Figure 65. Asia Pacific Immunosuppressant Drugs Revenue Market Share by Region in 2020
    Figure 66. China Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 67. China Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. Japan Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 69. Japan Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. South Korea Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 71. South Korea Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. India Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 73. India Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. Australia Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 75. Australia Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Taiwan Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 77. Taiwan Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Indonesia Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 79. Indonesia Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Thailand Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 81. Thailand Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Malaysia Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 83. Malaysia Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Philippines Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 85. Philippines Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Vietnam Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 87. Vietnam Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Latin America Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K MT)
    Figure 89. Latin America Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 90. Latin America Immunosuppressant Drugs Sales Market Share by Country in 2020
    Figure 91. Latin America Immunosuppressant Drugs Revenue Market Share by Country in 2020
    Figure 92. Mexico Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 93. Mexico Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 94. Brazil Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 95. Brazil Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Argentina Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 97. Argentina Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Middle East and Africa Immunosuppressant Drugs Sales Growth Rate 2016-2021 (K MT)
    Figure 99. Middle East and Africa Immunosuppressant Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 100. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Country in 2020
    Figure 101. Middle East and Africa Immunosuppressant Drugs Revenue Market Share by Country in 2020
    Figure 102. Turkey Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 103. Turkey Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 104. Saudi Arabia Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 105. Saudi Arabia Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. UAE Immunosuppressant Drugs Sales Growth Rate (2016-2021) (K MT)
    Figure 107. UAE Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 108. Immunosuppressant Drugs Value Chain
    Figure 109. Channels of Distribution
    Figure 110. Distributors Profiles
    Figure 111. Bottom-up and Top-down Approaches for This Report
    Figure 112. Data Triangulation
    Figure 113. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and Japan qPCR Kits Market Insights Forecast to 2027
Global and Japan qPCR Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-39Y7542
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Human ELISA Kits Market Insights Forecast to 2027
Global and China Human ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7484
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States PCR Amplifier Market Insights Forecast to 2027
Global and United States PCR Amplifier Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6W7895
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Porcine ELISA Kits Market Insights Forecast to 2027
Global and China Porcine ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37N7620
Wed Nov 24 00:00:00 UTC 2021

Add to Cart